Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Asherson

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Psychiatric Genetics|January 1, 1996
Linkage analysis of the fragile X gene FMR-1 and schizophrenia: no evidence for linkage but report of a family with schizophrenia and an unstable triplet repeatA Ashworth, I Abusaad, C Walsh, et al.
American Journal of Medical Genetics|April 24, 1995
Linkage studies on chromosome 22 in familial schizophreniaH P Vallada, M Gill, P Sham, et al.
American Journal of Medical Genetics|January 23, 2002
No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorderL Kent, E Green, J Holmes, et al.
Molecular Psychiatry|May 3, 2002
The dopamine D4 receptor and the hyperactivity phenotype: a developmental-epidemiological studyJ S Mill, A Caspi, J McClay, et al.
Nature Genetics|September 1, 1992
Schizophrenia scepticismR Mant, P Asherson, M Gill, et al.
Journal of Psychopharmacology (Oxford, England)|November 10, 2006
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyD J Nutt, K Fone, P Asherson, et al.
American Journal of Medical Genetics|May 31, 1997
Linkage study of chromosome 6p in sib-pairs with schizophreniaJ K Daniels, G Spurlock, N M Williams, et al.
Health Technology Assessment (Winchester, England)|November 4, 2009
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative studyI C K Wong, P Asherson, A Bilbow, et al.
The American Journal of Psychiatry|February 1, 1996
No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activityJ K Daniels, N M Williams, J Williams, et al.
Molecular Psychiatry|August 14, 1998
A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorderP Asherson, R Mant, N Williams, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Psychiatric Genetics|January 1, 1996
Linkage analysis of the fragile X gene FMR-1 and schizophrenia: no evidence for linkage but report of a family with schizophrenia and an unstable triplet repeatA Ashworth, I Abusaad, C Walsh, et al.
American Journal of Medical Genetics|April 24, 1995
Linkage studies on chromosome 22 in familial schizophreniaH P Vallada, M Gill, P Sham, et al.
American Journal of Medical Genetics|January 23, 2002
No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorderL Kent, E Green, J Holmes, et al.
Molecular Psychiatry|May 3, 2002
The dopamine D4 receptor and the hyperactivity phenotype: a developmental-epidemiological studyJ S Mill, A Caspi, J McClay, et al.
Nature Genetics|September 1, 1992
Schizophrenia scepticismR Mant, P Asherson, M Gill, et al.
Journal of Psychopharmacology (Oxford, England)|November 10, 2006
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyD J Nutt, K Fone, P Asherson, et al.
American Journal of Medical Genetics|May 31, 1997
Linkage study of chromosome 6p in sib-pairs with schizophreniaJ K Daniels, G Spurlock, N M Williams, et al.
Health Technology Assessment (Winchester, England)|November 4, 2009
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative studyI C K Wong, P Asherson, A Bilbow, et al.
The American Journal of Psychiatry|February 1, 1996
No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activityJ K Daniels, N M Williams, J Williams, et al.
Molecular Psychiatry|August 14, 1998
A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorderP Asherson, R Mant, N Williams, et al.
Pageof 11